- The Philadelphia metro area ranked number three as a metropolitan area with the largest total employment levels in the biosciences (medical device & equipment, drugs & pharmaceutical, research, testing & medical laboratories, and agricultural, feedstock & chemicals.) Source: Bioscience 07: Growing the Nation’s Bioscience Sector, Prepared by Battelle, January 2007.
- Philadelphia ranked in the top 10 metropolitan areas with largest employment in medical devices and equipment. Philadelphia is an example of a region that is not niched in one speciality, but excels in a combination of the bioscience subsectors. Source: Bioscience 07: Growing the Nation’s Bioscience Sector, Prepared by Battelle, January 2007.
- The medical device market in the United States should be approximately $86 billion by the end of 2006 (close to $220 billion worldwide), with a 10% annual growth rate expected for the coming year. Source: AdvaMed 2006
- The market for coatings and surface-treatment processes used on medical devices will reach more than $5.31 billion by 2010. The 12.4% annual growth rate will be fueled by explosive growth in high-value combination products. Source: Medical Device Coatings Report, BCC Research, April 2006
- During period of 2001-1006, California companies - $23.9 billion of increased market value creation, followed by Indiana at $22.9 billion, and Massachusetts at $20.7 billion. Source: Medical Device Industry Market Capitalization Report, 2001–2006
- The medical devices and equipment industry employs more than 411,400 workers, accounting for nearly one third of all US bioscience jobs. Source: Medical Product Outsourcing 2006
- Pennsylvania and New York included in Top 5 US states for Medical Device Employment - The thriving medical device industry in Massachusetts is the East Coast equivalent of the San Francisco Bay Area. Source: US Bureau of Labor Statistics, 2005
- The spinal devices segment (of the marketplace), with a striking growth rate of 20 to 25 percent annually, leads the orthopedic market. Extensive research on bone growth factors and fusion biologics has been integral to emerging technologies for the spine market. Source: Frost & Sullivan’s Emerging Technologies for the Spine Market (Technical Insights), published September 2006
Saturday, September 13, 2008
Subscribe to:
Posts (Atom)
